Z
Zanfina Ademi
Researcher at Monash University
Publications - 186
Citations - 33911
Zanfina Ademi is an academic researcher from Monash University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 22, co-authored 137 publications receiving 26399 citations. Previous affiliations of Zanfina Ademi include University of Basel & Alfred Hospital.
Papers
More filters
Journal ArticleDOI
Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients
Enayet K. Chowdhury,Robyn G Langham,Zanfina Ademi,Zanfina Ademi,Alice J. Owen,Henry Krum,Lindon M H Wing,Mark Nelson,Christopher M. Reid +8 more
TL;DR: In elderly persons with treated hypertension, a rapid decline in eGFR is associated with a higher risk of mortality.
Journal ArticleDOI
Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.
TL;DR: Although the dispensed price of diuretic- based treatment of hypertension in the elderly is lower, upon considering the potential enhanced likelihood of the development of diabetes in addition to the costs of treating cardiovascular disease, ACEI-based treatment may be a more cost-effective strategy in this population.
Journal ArticleDOI
The impact of diabetes on the productivity and economy of Bangladesh
Afsana Afroz,Thomas R. Hird,Ella Zomer,Alice J. Owen,Lei Chen,Zanfina Ademi,Danny Liew,Dianna J. Magliano,Baki Billah +8 more
TL;DR: In Bangladesh, the impact of diabetes on productivity loss and the broader economy looms large, and poses a substantial risk to the country’s future prosperity.
Journal ArticleDOI
The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction.
TL;DR: Compared with statin alone, icosapent ethyl in combination withstatin therapy is likely to be cost-effective in the prevention of cardiovascular disease assuming a willingness-to-pay threshold of AUD50,000 per QALY gained, especially in the secondary preventive setting.
Journal ArticleDOI
Quantifying the excess cost and resource utilisation for patients with complications associated with elective knee arthroscopy: A retrospective cohort study
Megan Bohensky,Megan Bohensky,Zanfina Ademi,Richard deSteiger,Danny Liew,Vijaya Sundararajan,Vijaya Sundararajan,Andrew Bucknill,Christos M Kondogiannis,Caroline Brand,Caroline Brand +10 more
TL;DR: This is the first study to quantify resource utilisation for complications associated with elective knee arthroscopy, using routinely collected hospital data from Victorian public hospitals during the period from 1 July 2000 to 30 June 2009 to examine relative cost and length of stay.